Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

BUY
$0.63 - $2.96 $10,562 - $49,627
16,766 Added 59.1%
45,133 $77,000
Q3 2021

Nov 12, 2021

BUY
$4.06 - $5.8 $26,503 - $37,862
6,528 Added 29.89%
28,367 $128,000
Q2 2021

Aug 06, 2021

BUY
$5.02 - $7.05 $38,548 - $54,136
7,679 Added 54.23%
21,839 $128,000
Q1 2021

May 14, 2021

SELL
$4.81 - $10.34 $37,542 - $80,703
-7,805 Reduced 35.53%
14,160 $96,000
Q4 2020

Feb 12, 2021

SELL
$4.13 - $6.41 $5,356 - $8,313
-1,297 Reduced 5.58%
21,965 $108,000
Q3 2020

Nov 13, 2020

BUY
$4.82 - $7.72 $112,122 - $179,582
23,262 New
23,262 $138,000
Q4 2019

Feb 12, 2020

SELL
$3.0 - $16.43 $53,106 - $290,843
-17,702 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$3.93 - $15.35 $15,629 - $61,046
3,977 Added 28.98%
17,702 $71,000
Q2 2019

Aug 20, 2019

BUY
$12.81 - $25.67 $66,996 - $134,254
5,230 Added 61.57%
13,725 $204,000
Q1 2019

May 15, 2019

SELL
$17.66 - $30.28 $450,241 - $771,988
-25,495 Reduced 75.01%
8,495 $211,000
Q4 2018

Feb 14, 2019

BUY
$11.63 - $32.67 $260,302 - $731,219
22,382 Added 192.82%
33,990 $611,000
Q1 2018

May 15, 2018

SELL
$50.12 - $67.72 $1.57 Million - $2.12 Million
-31,340 Reduced 72.97%
11,608 $613,000
Q4 2017

Feb 14, 2018

SELL
$57.69 - $84.58 $1.75 Million - $2.56 Million
-30,292 Reduced 41.36%
42,948 $2.92 Million
Q3 2017

Nov 15, 2017

BUY
$67.17 - $84.81 $4.92 Million - $6.21 Million
73,240
73,240 $6.04 Million

Others Institutions Holding CLVS

# of Institutions
1
Shares Held
166
Call Options Held
0
Put Options Held
0

About Clovis Oncology, Inc.


  • Ticker CLVS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 144,480,000
  • Market Cap $13M
  • Description
  • Clovis Oncology, Inc., a biopharmaceutical company, focuses on acquiring, developing, and commercializing anti-cancer agents in the United States, Europe, and internationally. In the U.S., the company offers Rubraca (rucaparib), an oral small molecule inhibitor of poly ADP-ribose polymerase for recurrent epithelial ovarian, fallopian tube, or pr...
More about CLVS
Track This Portfolio

Track Wolverine Trading, LLC Portfolio

Follow Wolverine Trading, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.